Suezawa, Takahiro
Kanagaki, Shuhei
Korogi, Yohei
Nakao, Kazuhisa
Hirai, Toyohiro
Murakami, Koji
Hagiwara, Masatoshi
Gotoh, Shimpei http://orcid.org/0000-0002-8563-8200
Funding for this research was provided by:
japan society for the promotion of science (JP15K21114)
japan agency for medical research and development (JP16bm0704008)
kyorin pharmaceutical co.ltd.
Article History
Received: 4 August 2021
Accepted: 22 October 2021
First Online: 4 November 2021
Declarations
:
: Teratoma formation assay was performed under approval by Animal Research Committee of Kyoto University. Using HFLFs was exemption from requiring ethics approval.
: Not applicable.
: T.S., S.K., K.N. and K.M. received personal fees and research funding from Kyorin Pharmaceutical Co., Ltd, and are shareholders of it. M.H. and S.G. are founders and shareholders of HiLung Inc. M.H. received research funding from Kyorin Pharmaceutical. S.G. is listed as one of the inventors of Kyoto University’s patents related to the method of generating alveolar organoids. The other authors declared no competing interest.